We are live on ! Find out more
OCGN icon

Ocugen

81 hedge funds and large institutions have $54M invested in Ocugen in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 24 increasing their positions, 7 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

258% more capital invested

Capital invested by funds: $15.1M → $54M (+$38.9M)

243% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 7

93% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 14

77% more call options, than puts

Call options by funds: $1.33M | Put options by funds: $750K

19% more funds holding

Funds holding: 6881 (+13)

2.62% more ownership

Funds ownership: 10.23%12.85% (+2.6%)

Holders
81
Holders Change
+13
Holders Change %
+19.12%
% of All Funds
1.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
27
Increased
24
Reduced
7
Closed
14
Calls
$1.33M
Puts
$750K
Net Calls
+$576K
Net Calls Change
+$301K

OCGN Hedge Fund Activity: Q1 2024 in Review

81 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Ocugen (OCGN) for Q1 2024, worth a combined $54M — up 258% from $15.1M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new OCGN positions and 14 closed out — a net gain of 13 holders — while 24 added to existing stakes and 7 trimmed.

The largest buyer was Goldman Sachs, opening a new position worth an estimated $2.19M. The largest seller was Luminus Management, exiting entirely with an estimated $935K sold.

  • 81 institutional investors held Ocugen (OCGN) as of Q1 2024, up from 68 in Q4 2023.
  • Funds reported $54M of Ocugen stock for Q1 2024, up 258% quarter-over-quarter.
  • 27 funds opened new Ocugen positions in Q1 2024 and 14 closed out, a net change of +13 holders.
  • The largest Ocugen buyer in Q1 2024 was Goldman Sachs, an estimated $2.19M added.
  • The largest Ocugen seller in Q1 2024 was Luminus Management, an estimated $935K sold.

Based on aggregated 13F filings for Q1 2024.